Ventyx Biosciences (VTYX) Competitors $2.30 -0.09 (-3.77%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$2.37 +0.07 (+3.22%) As of 09/19/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VTYX vs. KURA, RLAY, BGM, SANA, TBPH, MNMD, MAZE, RZLT, TRML, and TYRAShould you be buying Ventyx Biosciences stock or one of its competitors? The main competitors of Ventyx Biosciences include Kura Oncology (KURA), Relay Therapeutics (RLAY), BGM Group (BGM), Sana Biotechnology (SANA), Theravance Biopharma (TBPH), Mind Medicine (MindMed) (MNMD), Maze Therapeutics (MAZE), Rezolute (RZLT), Tourmaline Bio (TRML), and Tyra Biosciences (TYRA). These companies are all part of the "pharmaceutical products" industry. Ventyx Biosciences vs. Its Competitors Kura Oncology Relay Therapeutics BGM Group Sana Biotechnology Theravance Biopharma Mind Medicine (MindMed) Maze Therapeutics Rezolute Tourmaline Bio Tyra Biosciences Ventyx Biosciences (NASDAQ:VTYX) and Kura Oncology (NASDAQ:KURA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends. Which has more risk & volatility, VTYX or KURA? Ventyx Biosciences has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Kura Oncology has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500. Do analysts rate VTYX or KURA? Ventyx Biosciences currently has a consensus price target of $7.50, suggesting a potential upside of 226.09%. Kura Oncology has a consensus price target of $24.10, suggesting a potential upside of 192.12%. Given Ventyx Biosciences' higher probable upside, analysts clearly believe Ventyx Biosciences is more favorable than Kura Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ventyx Biosciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Kura Oncology 0 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.80 Do institutionals and insiders hold more shares of VTYX or KURA? 97.9% of Ventyx Biosciences shares are owned by institutional investors. 14.5% of Ventyx Biosciences shares are owned by insiders. Comparatively, 6.4% of Kura Oncology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media prefer VTYX or KURA? In the previous week, Kura Oncology had 10 more articles in the media than Ventyx Biosciences. MarketBeat recorded 10 mentions for Kura Oncology and 0 mentions for Ventyx Biosciences. Kura Oncology's average media sentiment score of 0.66 beat Ventyx Biosciences' score of 0.00 indicating that Kura Oncology is being referred to more favorably in the news media. Company Overall Sentiment Ventyx Biosciences Neutral Kura Oncology Positive Is VTYX or KURA more profitable? Ventyx Biosciences' return on equity of -48.89% beat Kura Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Ventyx BiosciencesN/A -48.89% -44.87% Kura Oncology N/A -52.32%-29.59% Which has stronger earnings and valuation, VTYX or KURA? Ventyx Biosciences has higher earnings, but lower revenue than Kura Oncology. Kura Oncology is trading at a lower price-to-earnings ratio than Ventyx Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVentyx BiosciencesN/AN/A-$135.12M-$1.68-1.37Kura Oncology$53.88M13.29-$173.98M-$2.26-3.65 SummaryVentyx Biosciences beats Kura Oncology on 8 of the 15 factors compared between the two stocks. Get Ventyx Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for VTYX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VTYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VTYX vs. The Competition Export to ExcelMetricVentyx BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$164.01M$3.14B$5.78B$10.46BDividend YieldN/A2.35%5.61%4.61%P/E Ratio-1.3720.9180.5026.81Price / SalesN/A416.22503.13112.35Price / CashN/A46.4637.6661.43Price / Book0.649.6015.756.39Net Income-$135.12M-$53.22M$3.30B$271.80M7 Day PerformanceN/A3.11%5.35%3.49%1 Month Performance-10.16%7.56%8.09%9.90%1 Year PerformanceN/A11.15%81.33%28.62% Ventyx Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VTYXVentyx Biosciences1.7768 of 5 stars$2.30-3.8%$7.50+226.1%-3.0%$164.01MN/A-1.3730High Trading VolumeKURAKura Oncology4.0216 of 5 stars$8.14-1.0%$24.10+196.1%-60.9%$713.47M$53.88M-3.60130RLAYRelay Therapeutics2.6072 of 5 stars$4.06-1.5%$17.50+331.0%-40.7%$710.34M$10.01M-2.08330Positive NewsBGMBGM Group0.2189 of 5 stars$7.33+1.1%N/A+22.9%$704.86M$25.10M0.00298Gap DownSANASana Biotechnology3.135 of 5 stars$3.00+1.4%$8.00+166.7%-33.1%$703.91MN/A-2.83380TBPHTheravance Biopharma3.325 of 5 stars$13.92-0.2%$21.33+53.3%+69.1%$702.54M$64.38M58.00110Short Interest ↑MNMDMind Medicine (MindMed)2.1735 of 5 stars$9.39+1.8%$24.71+163.2%+43.3%$701.53MN/A-6.1440MAZEMaze Therapeutics3.4822 of 5 stars$14.97-5.7%$26.33+75.9%N/A$696.35M$167.50M0.00121Analyst ForecastInsider TradeRZLTRezolute3.1899 of 5 stars$7.95-0.6%$12.50+57.2%+59.8%$695.97MN/A-6.9140Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap UpTRMLTourmaline Bio0.8595 of 5 stars$30.18+12.9%$50.14+66.1%+111.2%$687.00MN/A-8.8044High Trading VolumeTYRATyra Biosciences1.8947 of 5 stars$12.13-4.1%$31.43+159.1%-47.9%$674.21MN/A-6.8120 Related Companies and Tools Related Companies Kura Oncology Competitors Relay Therapeutics Competitors BGM Group Competitors Sana Biotechnology Competitors Theravance Biopharma Competitors Mind Medicine (MindMed) Competitors Maze Therapeutics Competitors Rezolute Competitors Tourmaline Bio Competitors Tyra Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VTYX) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ventyx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ventyx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VTYX Stock Alerts